| Eric Walburn Metzler, MD | |
|
1203 Highway 60, Socorro, NM 87801-5816 | |
| (575) 835-2724 | |
| (575) 835-4378 |
| Full Name | Eric Walburn Metzler |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 41 Years |
| Location | 1203 Highway 60, Socorro, New Mexico |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144289851 | NPI | - | NPPES |
| 76133737 | Medicaid | NM |
| Facility Name | Location | Facility Type |
|---|---|---|
| Heritage Home Healthcare & Hospice | Albuquerque, NM | Hospice |
| Onpointe Hospice | Albuquerque, NM | Hospice |
| Ambercare Hospice | Albuquerque, NM | Hospice |
| Hospice Of New Mexico, Llc | Albuquerque, NM | Hospice |
| Rio Rancho Center | Rio rancho, NM | Nursing home |
| Good Samaritan Society - Socorro | Socorro, NM | Nursing home |
| Uptown Rehabilitation Center | Albuquerque, NM | Nursing home |
| The Rio At Las Estancias | Albuquerque, NM | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| New Mexico Pac Services Pc | 3072889211 | 6 |
| Nm Pacs 2 Llc | 3375892060 | 63 |
News Archive
Duchenne muscular dystrophy research at the University of Florida got a major boost with the award of $7.5 million in National Institutes of Health funding to study the use of magnetic resonance imaging in determining the natural progression of the disease.
A multicenter team of investigators led by the University of California, San Diego School of Medicine has demonstrated, for the first time, the safety and efficacy of a targeted medication to shrink advanced kidney cancers prior to partial kidney removal and reconstruction. Their findings were published in the April 2010 online edition of BJU International.
Seattle Genetics, Inc.today announced that it has entered into a collaboration agreement with Abbott under which Abbott will pay an upfront fee of $8 million for rights to utilize Seattle Genetics' antibody-drug conjugate technology with antibodies to a single oncology target.
China Health Labs & Diagnostics Ltd., is pleased to announce that effective March 10, 2011 its shares began trading on the OTC Market's premier tier, OTCQX International, under the symbol CHLBF.
Women who stand for long periods while they are pregnant risk hampering the growth of their developing fetus, researchers say in Occupational and Environmental Medicine.
› Verified 2 days ago
| Entity Name | Ipc Hospitalists Of New Mexico, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578839163 PECOS PAC ID: 6800051509 Enrollment ID: O20120703000044 |
News Archive
Duchenne muscular dystrophy research at the University of Florida got a major boost with the award of $7.5 million in National Institutes of Health funding to study the use of magnetic resonance imaging in determining the natural progression of the disease.
A multicenter team of investigators led by the University of California, San Diego School of Medicine has demonstrated, for the first time, the safety and efficacy of a targeted medication to shrink advanced kidney cancers prior to partial kidney removal and reconstruction. Their findings were published in the April 2010 online edition of BJU International.
Seattle Genetics, Inc.today announced that it has entered into a collaboration agreement with Abbott under which Abbott will pay an upfront fee of $8 million for rights to utilize Seattle Genetics' antibody-drug conjugate technology with antibodies to a single oncology target.
China Health Labs & Diagnostics Ltd., is pleased to announce that effective March 10, 2011 its shares began trading on the OTC Market's premier tier, OTCQX International, under the symbol CHLBF.
Women who stand for long periods while they are pregnant risk hampering the growth of their developing fetus, researchers say in Occupational and Environmental Medicine.
› Verified 2 days ago
| Entity Name | New Mexico Pac Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801325634 PECOS PAC ID: 3072889211 Enrollment ID: O20171016003197 |
News Archive
Duchenne muscular dystrophy research at the University of Florida got a major boost with the award of $7.5 million in National Institutes of Health funding to study the use of magnetic resonance imaging in determining the natural progression of the disease.
A multicenter team of investigators led by the University of California, San Diego School of Medicine has demonstrated, for the first time, the safety and efficacy of a targeted medication to shrink advanced kidney cancers prior to partial kidney removal and reconstruction. Their findings were published in the April 2010 online edition of BJU International.
Seattle Genetics, Inc.today announced that it has entered into a collaboration agreement with Abbott under which Abbott will pay an upfront fee of $8 million for rights to utilize Seattle Genetics' antibody-drug conjugate technology with antibodies to a single oncology target.
China Health Labs & Diagnostics Ltd., is pleased to announce that effective March 10, 2011 its shares began trading on the OTC Market's premier tier, OTCQX International, under the symbol CHLBF.
Women who stand for long periods while they are pregnant risk hampering the growth of their developing fetus, researchers say in Occupational and Environmental Medicine.
› Verified 2 days ago
| Entity Name | Gps Physician Group, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881109452 PECOS PAC ID: 9739447400 Enrollment ID: O20180103001472 |
News Archive
Duchenne muscular dystrophy research at the University of Florida got a major boost with the award of $7.5 million in National Institutes of Health funding to study the use of magnetic resonance imaging in determining the natural progression of the disease.
A multicenter team of investigators led by the University of California, San Diego School of Medicine has demonstrated, for the first time, the safety and efficacy of a targeted medication to shrink advanced kidney cancers prior to partial kidney removal and reconstruction. Their findings were published in the April 2010 online edition of BJU International.
Seattle Genetics, Inc.today announced that it has entered into a collaboration agreement with Abbott under which Abbott will pay an upfront fee of $8 million for rights to utilize Seattle Genetics' antibody-drug conjugate technology with antibodies to a single oncology target.
China Health Labs & Diagnostics Ltd., is pleased to announce that effective March 10, 2011 its shares began trading on the OTC Market's premier tier, OTCQX International, under the symbol CHLBF.
Women who stand for long periods while they are pregnant risk hampering the growth of their developing fetus, researchers say in Occupational and Environmental Medicine.
› Verified 2 days ago
| Entity Name | Nm Pacs 2 Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366928749 PECOS PAC ID: 3375892060 Enrollment ID: O20180814000050 |
News Archive
Duchenne muscular dystrophy research at the University of Florida got a major boost with the award of $7.5 million in National Institutes of Health funding to study the use of magnetic resonance imaging in determining the natural progression of the disease.
A multicenter team of investigators led by the University of California, San Diego School of Medicine has demonstrated, for the first time, the safety and efficacy of a targeted medication to shrink advanced kidney cancers prior to partial kidney removal and reconstruction. Their findings were published in the April 2010 online edition of BJU International.
Seattle Genetics, Inc.today announced that it has entered into a collaboration agreement with Abbott under which Abbott will pay an upfront fee of $8 million for rights to utilize Seattle Genetics' antibody-drug conjugate technology with antibodies to a single oncology target.
China Health Labs & Diagnostics Ltd., is pleased to announce that effective March 10, 2011 its shares began trading on the OTC Market's premier tier, OTCQX International, under the symbol CHLBF.
Women who stand for long periods while they are pregnant risk hampering the growth of their developing fetus, researchers say in Occupational and Environmental Medicine.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Eric Walburn Metzler, MD Po Box 1279, Socorro, NM 87801-1279 Ph: (505) 858-1222 | Eric Walburn Metzler, MD 1203 Highway 60, Socorro, NM 87801-5816 Ph: (575) 835-2724 |
News Archive
Duchenne muscular dystrophy research at the University of Florida got a major boost with the award of $7.5 million in National Institutes of Health funding to study the use of magnetic resonance imaging in determining the natural progression of the disease.
A multicenter team of investigators led by the University of California, San Diego School of Medicine has demonstrated, for the first time, the safety and efficacy of a targeted medication to shrink advanced kidney cancers prior to partial kidney removal and reconstruction. Their findings were published in the April 2010 online edition of BJU International.
Seattle Genetics, Inc.today announced that it has entered into a collaboration agreement with Abbott under which Abbott will pay an upfront fee of $8 million for rights to utilize Seattle Genetics' antibody-drug conjugate technology with antibodies to a single oncology target.
China Health Labs & Diagnostics Ltd., is pleased to announce that effective March 10, 2011 its shares began trading on the OTC Market's premier tier, OTCQX International, under the symbol CHLBF.
Women who stand for long periods while they are pregnant risk hampering the growth of their developing fetus, researchers say in Occupational and Environmental Medicine.
› Verified 2 days ago
Kathleen Cathey, DNP, C-FNP Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1300 Enterprise Rd, Socorro, NM 87801 Phone: 575-835-4444 | |
Darla H Bejnar, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1204 Us Highway 60 West, Socorro General Medical Group, Socorro, NM 87801 Phone: 575-838-4690 Fax: 575-838-4689 | |
Dr. Farinaz Khan, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1202 Highway 60, Socorro, NM 87801 Phone: 575-835-1140 | |
Dr. Ravi Bhasker, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 Neel Ave, Socorro, NM 87801 Phone: 575-835-2940 Fax: 575-835-2216 | |
Dr. Norman John Reid, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1204 Highway 60, Socorro, NM 87801 Phone: 505-835-8370 Fax: 505-835-3828 | |
Robert E Markwell, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1204 Us Highway 60 West, Socorro General Medical Group, Socorro, NM 87801 Phone: 575-838-4690 Fax: 575-838-4689 |